We are excited to expand our services to the Forth Worth area!

Now online Clinical Cancer Research : Preop SAbR in #PancreaticCancer is associated with locoregional control—especially with arterial involvement—and reveals immune activation. Peter Leung was outstanding leading this to pub! #RadOnc UTSW Simmons Cancer Center @UTSWNews bit.ly/457oz6b

Congrats Ethan Ludmir MD and Chad Tang, MD for this publication's recognition as a recipient of the MD Anderson Cancer Center Excellence in Science Award. #endcancer #radonc ascopubs.org/doi/10.1200/JC…

Strong work done by our amazing students, Gabrielle Gard and Cole Ferguson and our incoming resident, Geina Iskander, MD ! Thanks Mary Mahoney MD for sharing the pictures and so sad that I missed ROECSG (Rad Onc Education Collab Study Group)

Congrats to our 5 graduating residents: Drs. Maureen Aliru, Ahmed Elamir, Meng-Lun Hsieh, Misha Miljanic, & Steven Montalvo. Great doctors & even better people! (Graduation was early this year, meaning we get another month w these awesome seniors). Gonna miss them so much ❤️

🤞2nd patient soon! ULTRAS is a Ph3 RCT (PI Ali Hosni) of 2 dose levels for 1 fx MR-guided SBRT for liver mets. A hesitation w 1 fx CT-based RT was risk of marginal miss. W better visualization & on table adaptation, I think MR-guided RT has great potential in this setting.

If you are seeking data that bridges the gap between bedside and benchside in pancreatic cancer research, look no further than Todd Aguilera MD PhD UTSW Radiation Oncology

Today we celebrate the retirement of a true giant in radiation oncology after 53 years. ❤️ Laura Dawson David Kirsch, MD, PhD

#CURiEAlert: The case report “Radiation Recall Phenomenon Following Vaccination in a Patient With Prior Radiation to Lower Extremity Liposarcoma,” authored by ACRO members Drs. Narine Wandrey & Mona Arbab, MD MEd w/ Anna Chung & Asal Rahimi M.D., M.S., is now published: cureus.com/articles/35498…

Lymph node stations of the thorax Illustration based on IASLC Michigan News anatomic guides

This is a major story from #ASCO25. Randomized phase 3 trial of time of day of immunotherapy infusion. Randomized to infusion before or after 3pm. Early infusion far superior: PFS 11.3 vs 5.7 HR 0.42, OS HR 0.45! Impactful, pragmatic, not costly. This should be a bigger story.

We have proposed something similar, replacing the PTV with an adaptive target volume (ATV). The ATV is a combination of contour uncertainty under adaptive conditions plus an adjustment for residual intra-fractional motion. Personally, I favor an adaptive target volume, because

Congratulations to our PGY3, Dr. Brett Tortelli! We can’t wait to see all the amazing research you will continue to do. UTSW Radiation Oncology

Love those enriching GI basic science talks…even embryology is so relevant to our field and not on Boards…e.g. blood supply to abdomen is embryology guided..CA foregut..SMA midgut…IMA hindgut UTSW Radiation Oncology Dr. Nina Niu Sanford

A. ElAmir, MD, M.Sc. Our ARRO Educator of the Year Award for 2025 was Dr. Mona Arbab!

Wonderful….

Just watched…10 min high yield pathology review in Pancreatic Cancer…smooth demonstration of what you need to know…UTSW Radiation Oncology Dr. Nina Niu Sanford

Surgical margin"S" in a pancreatic cancer surgical specimen is one of the most complicated......nice to the point work to smoothly elaborate...UTSW Radiation Oncology Dr. Nina Niu Sanford

🚨🚨🚨 We are activating this single-arm phase 2 trial of hypofractionated RT to oligoprogressive metastatic #melanoma, up to 10 lesions + extensive specimen collection for correlatives. There's an unmet need in this area - hope results of the trial will benefit more patients.

Our adaptive radiation therapy program, led by Shahed Badiyan and Mu-Han Lin, delivers real-time, personalized cancer treatment. Adaptive radiation therapy adjusts for daily anatomical changes—like tumor shrinkage or organ movement—enhancing precision and reducing side effects.